|
Jover E., Marín F., Quintana M., Pérez-Andreu J., Hurtado J.A., Rodríguez C., Martínez-González J., González-Conejero R., Valdés M., Hernández-Romero D. CALU polymorphism A29809G affects calumenin availability involving vascular calcification. Journal of Molecular and Cellular Cardiology. May 01, 2015. 82:218-227. 10.1016/j.yjmcc.2015.03.015
AÑO: 2015; IF: 4.874
|
25823396
|
Gallego P, Roldán V, Marin F, Gálvez J, Valdés M, Vicente V, Lip GY. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014 Nov;127(11):1083-8. doi: 10.1016/j.amjmed.2014.05.023. PubMed PMID: 24858062.
AÑO: 2014; IF: 5.003
|
|
García-Salas J., Tello-Montoliu A., Manzano-Fernández S., Casas-Pina T., Lõpez-Cuenca A., Pérez-Berbel P., Puche-Morenilla C., Martínez-Hernández P., Valdés M., Marín F. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients. International Journal of Clinical Practice. March 2014. 68:294-303. 10.1111/ijcp.12245
AÑO: 2014; IF: 2.566
|
|
Orenes-Piñero E, Hernández-Romero D, Romero-Aniorte AI, Martínez M, García-Honrubia A, Caballero L, Garrigos-Gómez N, Andreu-Cayuelas JM, González J, Feliu E, Climent V, Nicolás-Ruiz F, De La Morena G, Valdés M, Lip GY, Marín F. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM. 2014 Aug;107(8):613-21. doi: 10.1093/qjmed/hcu046. PubMed PMID: 24599807.
AÑO: 2014; IF: 2.495
|
|
Marín F., Díaz-Castro O., Ruiz-Nodar J.M., De La Villa B.G., Sionis A., López J., Fernández-Ortiz A., Martínez-Sellés M. Update on ischemic heart disease and critical care cardiology. Revista Espanola de Cardiologia. February 2014. 67:120-126. 10.1016/j.recesp.2013.10.007
AÑO: 2014; IF: 3.792
|